Clinical Trials
3 trialsNCT04283539 2023-11-13
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
National Jewish Health
Unknown
NCT03383952 2017-12-27
A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia
Immune Cell, Inc.
Phase 1 Unknown
NCT03383965 2017-12-27
CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas
Immune Cell, Inc.
Phase 1 Unknown